BACKGROUND Food insecurity is emerging as an important barrier to antiretroviral (ARV) adherence in sub-Saharan Africa and elsewhere, but little is known about the mechanisms through which food insecurity leads to ARV non-adherence and treatment interruptions. METHODOLOGY We conducted in-depth, open-ended interviews with 47 individuals (30 women, 17 men) living with HIV/AIDS recruited from AI...

BACKGROUND A major concern with using antiretroviral (ARV)-based products for HIV prevention is the potential spread of drug resistance, particularly from individuals who are HIV-infected but unaware of their status. Limited data exist on the prevalence of HIV infection or drug resistance among potential users of ARV-based prevention products. METHODS A cross-sectional study of reproductive-a...

We previously reported mother-to-child transmission of HIV-1 in nine (6.7%) of 135 children on nevirapine prophylaxis in Vietnam. In the current study, we investigated the appearance and profile of antiretroviral drug (ARV) resistance mutations, the predicted coreceptor usage, and the genetic diversity of HIV-1 strains isolated from the eight pairs of HIV-1-infected mothers and their children, ...

BACKGROUND HIV drug resistance surveillance is limited by recruitment and selection bias and by limited information regarding HIV incidence rates, secondary resistance, and treatment prevalence. METHODS A second-generation HIV sentinel surveillance among men who have sex with men (MSM), regardless of prior history of HIV screening, serostatus, or treatment, was conducted in Peru in 2002. Rece...

It is estimated globally 3.2 million children were living with HIV in 2014, that mostly in sub-Saharan Africa. However, the majority of them infected to HIV from their mothers during pregnancy, during delivery or breastfeeding (1). Antiretroviral therapy (ART) use during and after pregnancy is essential for prevention of mother-to-child transmission (PMTCT) of HIV (2).  In the absence of any in...

The increasing number of available antiretroviral drugs (ARV) for treating HIV-1 infection has promoted an amazing reduction on AIDS-associated morbidity and mortality. However, adverse events are still a frequent finding in on-treatment patients, and may have a negative impact on patient’s quality of life, adherence to therapy, and long term health problems.1 In Brazil, we have only scarce dat...

Introduction: Highly active antiretroviral therapy (HAART) leads to reconstitution of immune responses in HIV-infected patients. This may reveal an syndrome (IRS). While tuberculosis is the most common manifestation IRS southern countries, other more serious conditions such as Kaposi's disease it. Observation: We report a case revealing restoration with aim contributing better management. The p...

In July 2010, the World Health Organization (WHO) released new guidelines entitled, "Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Towards universal access." Previewed in November 2009 in abridged form, the completed document highlights the key WHO recommendations for antiretroviral treatment (ART) and prophylaxis in pregnant women, and contains subst...

Background: The use of ARV therapy has been shown to reduce the mortality and morbidity PLHIV. characteristic factor PLHIV health care system is a key as well how workers services synergize improve patient adherence taking ARVs. Subjects Method: This research was conducted using systematic review meta-analysis with PICO namely, Population: Intervention; mobile phone text message. Comparison: no...